Acorah Software Products - Accounts Production16.1.300falsetruefalsetrueNo description of principal activity25 October 202231 October 202331 October 202314441309Miss Daniela NOCERAiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure144413092022-10-24144413092023-10-31144413092022-10-252023-10-3114441309frs-core:CurrentFinancialInstruments2023-10-3114441309frs-bus:PrivateLimitedCompanyLtd2022-10-252023-10-3114441309frs-bus:FilletedAccounts2022-10-252023-10-3114441309frs-bus:Micro-entities2022-10-252023-10-3114441309frs-bus:AuditExempt-NoAccountantsReport2022-10-252023-10-3114441309frs-bus:Director12022-10-252023-10-31
Registered number: 14441309
DNA B2B Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2023
FIDCORP LIMITED
3rd Floor Portman House
2, Portman Street
London
W1H 6DU
DNA B2B Ltd
Balance Sheet
As At 31 October 2023
Balance Sheet
Registered number: 14441309
2023
£
Current assets
2,038
Creditors: Amounts Falling Due Within One Year
(5,094)
NET CURRENT LIABILITIES
(3,056)
TOTAL ASSETS LESS CURRENT LIABILITIES
(3,056)
NET LIABILITIES
(3,056)
CAPITAL AND RESERVES
(3,056)
Notes
1.General Information
DNA B2B Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14441309. The registered office is 3rd Floor Portman House, 2, Portman Street, London, W1H 6DU.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.